Thirty Pre-labeled Tubes and a Potassium of 6.9
07:00 in a busy outpatient lab with 30 patients booked before noon. A coworker, Dana, prints and labels 30 tubes at the start of the shift and lines them up on the rack so 'the line moves faster.' She has done it for years and says nothing has ever gone wrong. At 10:40 the chemistry tech calls with two problems: a potassium of 6.9 mmol/L on a 34-year-old with no cardiac history, and a label on that specimen bearing a draw time of 07:35 that was printed before the patient arrived. The patient is still in the waiting room for a second order. Dana says, 'Tell them it's probably hemolyzed. I'll redraw him next week if he comes back.' Monthly hemolysis at your site is 8% versus 2% at the sister site.
1. What do you do about the 6.9 potassium right now?
Read the worked answer
Treat it as critical and act within minutes, even though the specimen is suspect.
- Call the ordering provider, report the value as critical, and state the caveat in the same breath: the specimen also carries a labeling and timing discrepancy and is being recollected. Do not soften the number or delay the call while you investigate.
- Redraw immediately - the patient is in the waiting room, which is the best possible circumstance. Label at the chair, after identifying him, and send it stat with a note asking the lab to run it ahead of routine work.
- Ask the lab for the hemolysis index and check the delta against any prior potassium. Rule out EDTA carryover (a markedly low calcium and high potassium together points that way) and consider true hyperkalemia in a young patient - renal, endocrine, or drug-related.
Reasoning: hemolysis is a likely explanation, but 'probably hemolyzed' is not a diagnosis. If the 6.9 is real, the delay to next week could be fatal. The critical value and the specimen problem are reported together, not one instead of the other.
2. Evaluate Dana's pre-labeling practice and describe how you address it with her.
Read the worked answer
The practice is indefensible regardless of her track record, and the conversation has to happen today.
Why it fails: the label asserts an identity and a collection time before either exists. The failure mode is silent and severe - one patient's blood in another patient's tube, producing a result that looks valid and drives treatment. Here, a printed draw time of 07:35 before the patient arrived means the record contains fabricated data, which is a documentation integrity problem on top of the labeling problem.
How to address it:
- Privately, factually, no accusation of malice: describe what the pre-printed time on that specimen means and what a wrong-patient potassium would have done.
- Be explicit that every unused pre-labeled tube is discarded now - the labels are not 'wasted money,' they are unverified claims.
- Her suggestion to quietly redraw next week is concealment of a reportable event; say so plainly.
- Loop in the supervisor and complete the event report. Her years of practice without a visible incident are the reason this is urgent, not a reason to wait.
3. Design the quality response, including how you handle the 8% hemolysis rate.
Read the worked answer
Separate the two problems and fix each with the right tool.
Labeling: root cause is a workflow built for throughput with labeling done away from the patient. Countermeasures: label at the chair after two-identifier verification, barcode printing at the point of use or mobile phlebotomy carts, and a discarded-label rule. Audit any tubes still pre-labeled on the rack today and pull them. Re-train and observe competency for the whole shift, not just Dana, because a tolerated shortcut is a system norm.
Hemolysis (8% versus 2%): pre-labeling does not hemolyze blood, so the number needs its own investigation - audit needle gauge versus vein size, tourniquet time, underfilled tubes, shaking during transport, and how long specimens sit before centrifugation. Pull twenty recent hemolyzed specimens and compare them against the same draws at the sister site.
Closing the loop: nonconformance reports for both, a documented corrective action with an owner and a date, monthly re-audit of hemolysis and labeling errors, and a report to the quality committee. Track whether the numbers move; if they do not, the countermeasure was wrong.